Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;47(1):36-38.
doi: 10.1016/j.jdmv.2022.01.072. Epub 2022 Jan 17.

Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination

M Noyé  1 , A Sauvage  1 , M Toussaint  2 , R Benoit  2 , T Foret  3 , Jeremy Lagrange  4 , V Dufrost  3 , V Regnault  4 , S Zuily  3 , D G Wahl  5
Affiliations

Microvascular manifestations revealing vaccine-induced thrombotic thrombocytopenia after COVID-19 vaccination

M Noyé et al. J Med Vasc. 2022 Feb.

Erratum in

No abstract available

Keywords: Chilblain; Pernio; Raynaud disease; Thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; thrombocytopenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Microvascular manifestations after ChAdOx1 nCov-19 vaccination. Images show chilblain-like lesions on index (panel A, blue arrow), splinter hemorrhages on left thumb (panel B, yellow arrow) and swollen wrist (panel C, green arrow) associated with cold cyanosis of the left hand (panel C, red arrow). Diagram depicts the timeline of vaccination, symptoms, laboratory tests (Platelet count, D-dimers and anti-PF4/heparin antibodies) and treatment (panel D). PF4: platelet factor 4; IVIg: intravenous immunoglobulin.
See this image and copyright information in PMC

References

    1. Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384:2092–2101. - PMC - PubMed
    1. Freeman E.E., Sun Q., McMahon D.E., Singh R., Fathy R., Tyagi A., et al. Skin reactions to COVID-19 vaccines: an American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type. J Am Acad Dermatol. 2021 doi: 10.1016/j.jaad.2021.11.016. [S0190-9622(21)02841-3] - DOI - PMC - PubMed
    1. Gambichler T., Boms S., Susok L., Dickel H., Finis C., Abu Rached N., et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2021 doi: 10.1111/jdv.17744. - DOI - PMC - PubMed
    1. Pileri A., Guglielmo A., Raone B., Patrizi A. Chilblain lesions after COVID-19 mRNA vaccine. Br J Dermatol. 2021 doi: 10.1111/bjd.20060. - DOI - PMC - PubMed
    1. Thaler J., Ay C., Gleixner K.V., Hauswirth A.W., Cacioppo F., Grafeneder J., et al. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT) J Thromb Haemost. 2021;19:1819–1822. - PMC - PubMed

MeSH terms